The Biovac Institute is the result of a partnership formed with the South African government to establish vaccine manufacturer in South. The Company's vision is to be a health focused Centre of Excellence rooted in Africa for the development and manufacture of quality vaccines for Africa and the developing world’s needs. As the only Southern African human vaccines manufacturer, Biovac recognises the need for a domestic manufacturer of vaccines to enable the Southern African region to respond t...
- (21.Jul.2021) Pfizer and BioNTech Announce Collaboration With Biovac to Manufacture and Distribute COVID-19 Vaccine Doses Within Africa
- (18.Mar.2021) State-Backed Biovac Clinches Deal with ImmunityBio to Make Covid-19 Vaccines
- (14.Oct.2020) South Africa's Biovac in Talks to Manufacture COVID-19 Vaccines
- (06.Oct.2020) Biovac Selects TrackWise Digital to Enable Digital Quality Management Across Vaccine Manufacturing Operations